Inventor
POWIS GARTH
US22 patents
⚠️ This page may combine multiple inventors who share the name “POWIS GARTH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV ARIZONA
10 patentsUS5378725AJan 3, 1995
Inhibition of phosphatidylinositol 3-kinase with wortmannin and analogs thereof
UNIV ARIZONA121 citations96
US6703414B2Mar 9, 2004
Device and method for treating restenosis
UNIV ARIZONA64 citations94
US6379970B1Apr 30, 2002
Analysis of differential protein expression
UNIV ARIZONA67 citations93
US7081475B2Jul 25, 2006
Wortmannin analogs and methods of using same
UNIV ARIZONA16 citations92
US6689775B2Feb 10, 2004
Uses of thioredoxin
UNIV ARIZONA7 citations73
US6667340B1Dec 23, 2003
Inhibitors of phosphatidyl myo-inositol cycle
UNIV ARIZONA2 citations63
US7776908B2Aug 17, 2010
Wortmannin analogs and methods of using same
UNIV ARIZONA0 citations52
US7723375B2May 25, 2010
Metabolites of wortmannin analogs and methods of using the same
UNIV ARIZONA0 citations52
US7335679B2Feb 26, 2008
Wortmannin analogs and methods of using same
UNIV ARIZONA0 citations52
US7153843B2Dec 26, 2006
Inhibitors of phosphatidyl myo-inositol cycle
UNIV ARIZONA1 citations52
PROLX PHARMACEUTICALS CORP
4 patentsUS6372772B1Apr 16, 2002
Inhibitors of redox signaling and methods of using same
PROLX PHARMACEUTICALS CORP24 citations89
US7399785B2Jul 15, 2008
N-oxides and derivatives of melphalan for treating diseased states associated with hypoxia inducible factor
PROLX PHARMACEUTICALS CORP18 citations86
US7446124B2Nov 4, 2008
Wortmannin analogs and methods of using same in combination with chemotherapeutic agents
PROLX PHARMACEUTICALS CORP12 citations82
US7858657B2Dec 28, 2010
Wortmannin analogs and methods of using same in combination with chemotherapeutic agents
PROLX PHARMACEUTICALS CORP1 citations45